News

A plain language summary for patients explains there were no differences in safety outcomes between adalimumab-adbm and the ...
THUMBS UP & SUBSCRIBE HERE- <a href=" Thena Natural Wellness's Best Skin Healing Cream For Eczema, Psoriasis, Rosacea, Dermatitis, Heat Rash, Hives & More No more severely dry, itchy, scaly, cracked, ...
Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...
Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...
The hold, placed by the FDA on an early-stage clinical trial of an experimental BET inhibitor, stems from a recent ...
Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...
About 58% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin ...
Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...
Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...
Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...
A preclinical study finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity -- two issues that commonly co-occur with ...